Wu, Huizhe

Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation

Huang, H., Weng, H., Sun, W., Qin, X., Shi, H., Wu, H., Zhao, B. S., Mesquita, A., Liu, C., Yuan, C. L., et al. (2018) · Nature Cell Biology

RNA modifications and cancerRNA Research and Splicing

Cited by 2,997

Histone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally

Huang, H., Weng, H., Zhou, K., Wu, T., Zhao, B. S., Sun, M., Chen, Z., Deng, X., Xiao, G., Auer, F., et al. (2019) · Nature

RNA modifications and cancerEpigenetics and DNA Methylation

Cited by 677

The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia

Weng, H., Huang, F., Yu, Z., Chen, Z., Prince, E., Kang, Y., Zhou, K., Li, W., Hu, J., Fu, C., et al. (2022) · Cancer Cell

RNA modifications and cancerAcute Myeloid Leukemia Research

Cited by 336

N6-methyladenosine reader IMP2 stabilizes the ZFAS1/OLA1 axis and activates the Warburg effect: implication in colorectal cancer

Lu, S., Han, L., Hu, X., Sun, T., Xu, D., Li, Y., Chen, Q., Yao, W., He, M., Wang, Z., et al. (2021) · Journal of Hematology & Oncology

RNA modifications and cancerCancer, Hypoxia, and Metabolism

Cited by 116

A novel HIF-2α targeted inhibitor suppresses hypoxia-induced breast cancer stemness via SOD2-mtROS-PDI/GPR78-UPRER axis

Yan, Y., He, M., Zhao, L., Wu, H., Zhao, Y., Han, L., Wei, B., Ye, D., Lv, X., Wang, Y., et al. (2022) · Cell Death & Differentiation

Cancer, Hypoxia, and MetabolismCancer Cells and Metastasis

Cited by 101

LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer

Wu, H., Ding, X., Hu, X., Zhao, Q., Chen, Q., Sun, T., Li, Y., Guo, H., Li, M., Gao, Z., et al. (2022) · Oncogene

Cancer-related molecular mechanisms researchRNA modifications and cancer

Cited by 26